Colchicine in atrial fibrillation: mechanisms, highlights, and current evidence

Area of Science:

• Cardiology
• Pharmacology
• Inflammation Research

Background:

• Global incidence of atrial fibrillation (AF) is increasing, leading to severe complications like stroke and heart failure.
• Inflammatory responses are increasingly recognized as key contributors to AF pathogenesis.
• Colchicine, a well-established anti-inflammatory drug, has demonstrated potential in cardiovascular applications.

Purpose of the Study:

• To review the mechanisms by which colchicine may prevent AF.
• To discuss appropriate dosage strategies for colchicine in AF management.
• To summarize existing evidence on colchicine's efficacy in preventing AF across various clinical settings.

Main Methods:

• Literature review of studies investigating colchicine's role in AF.
• Analysis of preclinical and clinical data on colchicine's anti-inflammatory and cardiovascular effects.
• Synthesis of evidence from diverse patient populations and surgical contexts.

Main Results:

• Colchicine's anti-inflammatory properties may counteract AF-promoting pathways.
• Evidence suggests colchicine's potential benefit in preventing AF post-cardiac surgery and in specific patient groups.
• Further research is needed to establish optimal dosing and long-term outcomes.

Conclusions:

• Colchicine presents a potential therapeutic option for AF prevention, primarily through its anti-inflammatory actions.
• Accumulated evidence supports exploring colchicine's role in managing AF, particularly in high-risk populations.
• Future research should focus on large-scale clinical trials to confirm efficacy and safety profiles.